ParamergeParamerge

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH

Two-phase award: an R61 pilot or secondary-data phase to establish feasibility, then a milestone-gated R33 phase to test FASD prevention or intervention approaches at scale.

Indicative award
up to $500k per year (per year)R61 phase: up to $350,000 total over 2 years, max $225,000/year. R33 phase: up to $500,000 direct costs per year for up to 3 years. Combined period 5 years maximum.
Timing
Several times a yearSeveral times a year · Feb, Jun, OctNo specific published date recorded. This funder publishes a cycle rather than a date, and this database does not invent one.Recurring cycles beginning February 19, 2025; expiration November 18, 2026. The fetched page did not display a specific remaining future due date, so none is recorded here.
Who can apply
Early-career faculty, Mid-career & senior, Any faculty rank
Eligibility
Higher education institutions, nonprofits with or without 501(c)(3) status, for-profits, federal/state/local/tribal government agencies, faith- and community-based organizations, and foreign organizations. Transition to the R33 phase is contingent on meeting stated R61 milestones.
SSWR clusters
Topics
fetal alcohol spectrum disorders · prenatal alcohol exposure · phased intervention research · secondary data analysis
Apply at
https://grants.nih.gov/grants/guide/pa-files/PAR-25-158.html
This entry
Curated by the working group. Written 2026-08-07. The funder link has not yet been machine-checked.

Amounts and dates on this page are indicative and are maintained by people rather than scraped. Funders change ceilings, windows and eligibility without notice; confirm all details at the source above before applying.

← Back to the database